ID: ALA2376163

Max Phase: Preclinical

Molecular Formula: C21H24ClN5OS

Molecular Weight: 393.52

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)Nc1nc(CCc2ccc(NC(=N)N)cc2)c(Cc2ccccc2)s1.Cl

Standard InChI:  InChI=1S/C21H23N5OS.ClH/c1-14(27)24-21-26-18(19(28-21)13-16-5-3-2-4-6-16)12-9-15-7-10-17(11-8-15)25-20(22)23;/h2-8,10-11H,9,12-13H2,1H3,(H4,22,23,25)(H,24,26,27);1H

Standard InChI Key:  JQKRSKBTGHOZHI-UHFFFAOYSA-N

Associated Targets(Human)

Amine oxidase, copper containing 450 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Amine oxidase, copper containing 122 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 393.52Molecular Weight (Monoisotopic): 393.1623AlogP: 3.78#Rotatable Bonds: 7
Polar Surface Area: 103.89Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.30CX Basic pKa: 7.68CX LogP: 3.73CX LogD: 3.54
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.36Np Likeness Score: -0.95

References

1. Inoue T, Morita M, Tojo T, Nagashima A, Moritomo A, Imai K, Miyake H..  (2013)  Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema: part 2.,  21  (9): [PMID:23540955] [10.1016/j.bmc.2013.02.048]

Source